A panel in Japan has given the OK for the emergency use of the Pfizer-BioNTech SARS-CoV-2 vaccine, Bloomberg reports.
It adds that this greenlight from the Ministry of Health's advisory Pharmaceutical Affairs and Food Sanitation Council could enable the vaccine to be approved as early as Sunday. If that happens, Bloomberg notes this would be Japan's first SARS-CoV-2 vaccine approval.